Bupropion Sr/ Er Tablets Suppliers & Bulk Manufacturers
Available Forms: Sustained-Release (SR) Tablets, Extended-Release (XL) Tablets
Available Strengths: 100 mg, 150 mg, 200 mg (SR); 150 mg, 300 mg (XL)
Reference Brands: Wellbutrin® SR/XL(US); Zyban®(EU & US)
Category: Antipsychotropic Drugs
Bupropion SR/ ER Tablets is available in Sustained-Release (SR) Tablets, Extended-Release (XL) Tablets and strengths such as 100 mg, 150 mg, 200 mg (SR); 150 mg, 300 mg (XL). Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Bupropion SR/ ER Tablets is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.
| Technical Specifications & Supply Details | |
|---|---|
| Lead Time | 7 to 60 days (depending on batch size & schedule) |
| MOQ | As per manufacturer’s batch size |
| COA | Available with every batch |
| Regulatory Dossier / DMF | Available upon request |
| Export Documentation | FSC, COA, Manufacturing License, Product Permission |
| Standards | IP, BP, USP |
| Certifications | WHO-GMP, EU-GMP, USFDA (as applicable) |
Bupropion SR/ ER Tablets can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Product Description: Bupropion sustained-release (SR) and extended-release (ER) tablets are FDA-approved in the United States for the treatment of major depressive disorder (MDD) and seasonal affective disorder (SAD), and as an aid in smoking cessation under brand variations. U.S. regulations require Boxed Warnings regarding suicidal thoughts in young adults, seizure risk, and contraindications. Manufacturers must ensure GMP compliance, bioequivalence data, and post-marketing safety reporting. In the European Union, bupropion is authorized under national and centralized procedures for depression and smoking cessation. EU approval mandates a Risk Management Plan (RMP), Periodic Safety Update Reports (PSURs), and pharmacovigilance systems. For dossier-ready supply, visit Pharmatradz.com.
Frequently Asked Questions
Related Products
Risperidone Long-Acting Injection
Strength:
12.5 mg, 25 mg, 37.5 mg, 50 mg vials/syringes
Form: Long-Acting Injection
Reference Brands: Risperdal Consta(US &EU)
View Details
Zuclopenthixol Ong-Acting Im Injection (Depot)
Strength:
200 mg/mL, 500 mg/mL
Form: Long-acting IM Injection (Depot)
Reference Brands: Clopixol Depot®(US)
View Details
Zuclopenthixol Short-Acting Intramuscular Injection
Strength:
50 mg/mL
Form: Short-acting Intramuscular Injection
Reference Brands: Clopixol-Acuphase®
View Details
Zuclopenthixol Tablets
Strength:
10 mg, 25 mg, 40 mg
Form: Oral Tablets
Reference Brands: Clopixol®(EU)
View DetailsQuick Response Guaranteed | Verified Suppliers
